Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences.
about
Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal ToxinLocal therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out miceSAAG-4 is a novel mosquito salivary protein that programmes host CD4+T cells to express IL-4Type I interferon is required to mount an adaptive response to immunostimulatory DNAToll-like receptor 9-induced type I IFN protects mice from experimental colitis.Introduction to immunostimulatory DNA sequences.Pre-priming: a novel approach to DNA-based vaccination and immunomodulation.Mucosal adjuvanticity of immunostimulatory DNA sequences.Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.CpG oligonucleotide modulation of allergic inflammation.Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.Immunostimulatory DNA-based therapeutics for experimental and clinical allergy.Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications.Challenges facing adjuvants for cancer immunotherapy.Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cellsNovel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cellsEx vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation.Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy.CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans.Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy.Assessing the safety of adjuvanted vaccines.The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.Old and new adjuvants for hepatitis B vaccines.TNF-alpha downregulates the leukotriene C4 synthase gene in mononuclear phagocytes.Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism.Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
P2860
Q24673297-B5AEDD88-FEFC-4050-8CD1-71FA313F3410Q24804175-CFAA0613-A7AA-4385-A53F-01D75CD171A0Q27489884-8F8A9913-F2B0-4182-9BEC-9D8FE717E86DQ28508204-47F7EE92-F95D-4947-9B54-9DE4383057CFQ33683729-4BD293AB-ED1E-4A86-B799-034B5D95E9B9Q34005376-22B268D9-1219-446F-866E-7C061E10824AQ34005416-A76024A1-D07B-4D95-B370-27F6E2699949Q34005448-E740E2CF-D4A2-4713-A792-79248202AA5FQ34009281-A75D5A2F-00E0-4D19-8AAA-02F53AFDF10FQ34249599-0F69B22F-1A32-46FB-8DFA-377296F710FEQ34340988-954FE7B1-7765-48BD-8C10-D9091C3FF207Q34764668-CDDC6451-0798-400E-BA2B-9BE3A41B9931Q35826408-AF98A770-7B96-47E6-9E5E-15A58B77162CQ35953773-2CE186B9-8E82-48C4-BE82-8D59D1320792Q36089371-1217259E-1BCC-4148-8F9C-44B30ED9DA64Q36247625-D792592C-EB4C-4930-9C35-9B62C70D29FEQ36526337-8C870137-8902-4F52-A06E-D1794DDA4BD5Q36981682-77BD297F-0119-41B8-B71A-B44661C6D136Q37328524-60560AC3-49AE-44FF-B61B-4908200C3B37Q37867099-EC0FC697-2A4C-4E41-86BA-09C83C94FFD9Q37906961-DA51B08C-53BD-4F41-B7A0-4DBAC6D2E4BBQ38111651-BE085A59-0AEB-4D09-82E3-7A27DD248694Q38293586-37EB815E-C3D3-4576-9FB3-D115DC75C1EBQ40230872-43BAA8A5-508B-47AE-B180-361E750774FAQ41734956-50864ADE-4F62-4C9D-B2DF-5F39206C4406Q45090402-4E8A778A-662C-4B80-A3BD-577A6A9F6567
P2860
Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Enhancement of antigen-present ...... munostimulatory DNA sequences.
@en
type
label
Enhancement of antigen-present ...... munostimulatory DNA sequences.
@en
prefLabel
Enhancement of antigen-present ...... munostimulatory DNA sequences.
@en
P2093
P2860
P356
P1476
Enhancement of antigen-present ...... munostimulatory DNA sequences.
@en
P2093
Kobayashi H
Kornbluth RS
Martin-Orozco E
Van Uden J
P2860
P304
P356
10.1093/INTIMM/11.7.1111
P577
1999-07-01T00:00:00Z